Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.23.1
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Accounts payable:    
Clinical and regulatory expenses $ 393 $ 361
Professional fees 652 626
Selling expenses 1,756 1,363
Manufacturing costs 1,023 650
Non-employee board member compensation 552 484
Other vendors 357 301
Total accounts payable 4,733 3,785
Accrued interest payable, related parties 377 144
Accrued interest payable 2,595 2,381
Accrued expenses:    
Payroll expenses 1,241 1,263
Government rebates and other rebates 4,973 5,536
Other accrued expenses 504 440
Total accrued expenses 6,718 7,239
Total accounts payable and accrued expenses $ 14,423 $ 13,549